Inequity in colorectal cancer treatment and outcomes: A population-based study

British Journal of Cancer

Volumn 99, Issue 2, 2008, Pages 266-274

  Carsin, A E ^a   Sharp, L ^a   Cronin Fenton, D P ^b   Ceilleachair A O ^a   Comber, H ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chemotherapy; Colorectal cancer; Radiotherapy; Resection; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER MORPHOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COLON RESECTION; COLORECTAL CANCER; FEMALE; HUMAN; IRELAND; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECTUM TUMOR; TREATMENT OUTCOME; COLORECTAL TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; ONCOLOGY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 48249114379     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604467     Document Type: Article

References (54)

1. AJCC (American Joint Committee on Cancer) (2002) AJCC Cancer Staging Manual, 6th edn. Springer-Verlag: New York
2. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A, Multicenter International Study of Oxaliplatin/5-Fluorouracil/ Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators (2004a) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351
3. André T, de Gramont A, Oncology Multidisciplinary Research Group (2004b) An overview of adjuvant systemic chemotherapy for colon cancer. Clin Colorectal Cancer 4: S22-S28
4. André T, Sargent D, Tabernero J, O'Connell M, Buyse M, Sobrero A, Misset J, Boni C, de Gramont A (2006) Current issues in adjuvant treatment of stage II colon cancer. Ann Surg Oncol 13: 887-898
5. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee (2005) Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer, 2nd edn. The Cancer Council Australia and Australian Cancer Network: Sydney
6. Ayanian J, Zaslavsky A, Fuchs C, Guadagnoli E, Creech C, Cress R, O'Connor L, West D, Allen M, Wolf R, Wright W (2003) Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21: 1293-1300
7. Benson III AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22: 3408-3419
8. Bouchardy C, Queneau PE, Fioretta G, Usel M, Zellweger M, Neyroud I, Raymond L, de Wolf C, Sappino AP (2001) Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice. Br J Cancer 85: 1251-1257
9. Cascinu S, Catalano V, Piga A, Mattioli R, Marcellini M, Pancotti A, Bascioni RTU, Silva RR, Pieroni V, Giorgi F, Catalano G, Cellerino R (2003) The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole vs 5-fluorouracil alone. Cancer Invest 21: 701-707
10. Ciccolallo L, Capocaccia R, Coleman M, Berrino F, Coebergh J, Damhuis R, Faivre J, Martinez-Garcia C, Møller H, Ponz de Leon M, Launoy G, Raverdy N, Williams E, Gatta G (2005) Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 54: 268-273
11. Coleman M, Estève J, Damiecki P, Arslan A, Renard H (1993) Trends in Cancer Incidence and Mortality. IARC Scientific Publications No. 121 IARC: Lyon
12. Colorectal Cancer Collaborative Group (2000a) Surgery for colorectal cancer in elderly patients: a systematic review. Lancet 356: 968-974
13. Colorectal Cancer Collaborative Group (2000b) Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. BMJ 321: 531-535
14. Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358: 1291-1304
15. Cook A, Single R, McCahill L (2005) Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988-2000. Ann Surg Oncol 12: 637-645
16. Cronin D, Harlan L, Potosky A, Clegg L, Stevens J, Mooney M (2006) Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 101: 2308-2318
17. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97: 1407-1427
18. Expert Working Group on Radiation Oncology Services (2003) The Development of Radiation Oncology Services in Ireland. Department of Health & Children: Dublin
19. Faivre-Finn C, Benhamiche A, Maingon P, Janoray P, Faivre J (2000) Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population. Radiother Oncol 57: 137-142
20. Faivre-Finn C, Bouvier-Benhamiche A, Phelip J, Manfredi S, Dancourt V, Faivre J (2002) Colon cancer in France: evidence for improvement in management and survival. Gut 51: 60-64
21. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, Version 2.0. IARC Cancer Base No. 5 IARC Press: Lyon
22. Fracasso M, Doria D, Franceschetti P, Perbellini L, Romeo L (2006) DNA damage and repair capacity by comet assay in lymphocytes of white-collar active smokers and passive smokers (non- and ex-smokers) at workplace. Toxicol Lett 167: 131-141
23. Gatta G, Capocaccia R, Sant M, Bell C, Coebergh J, Damhuis R, Faivre J, Martinez-Garcia C, Pawlega J, Ponz de Leon M, Pottier D, Raverdy N, Williams E, Berrino F (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 47: 533-538
24. Gill S, Loprinzi C, Sargent D, Thomé S, Alberts S, Haller D, Benedetti J, Francini G, Shepherd L, Francois Seitz J, Labianca R, Chen W, Cha S, Heldebrant M, Goldberg R (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22: 1797-1806
25. Jadallah F, McCall J, van Rij A (1999) Recurrence and survival after potentially curative surgery for colorectal cancer. N Z Med J 112: 248-250
26. Jessup J, Stewart A, Greene F, Minsky B (2005) Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. J Am Med Assoc 294: 2703-2711
27. Konyalian V, Rosing D, Haukoos J, Dixon M, Sinow R, Bhaheetharan S, Stamos M, Kumar R (2007) The role of primary tumour resection in patients with stage IV colorectal cancer. Colorectal Dis 9: 430-437
28. Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J, Rockette H (1999) Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B vs Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17: 1349-1355
29. Martijn H, Voogd AC, van de Poll-Franse LV, Repelaer van Driel OJ, Rutten HJ, Coebergh JW (2003) Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer 39: 2073-2079
30. Munro A, Bentley A, Ackland C, Boyle P (2006) Smoking compromises cause-specific survival in patients with operable colorectal cancer. Clin Oncol (R Coll Radiol) 18: 436-440
31. NCR (National Cancer Registry) (2001) Cancer in Ireland, 1994 to 1998: Incidence, Mortality, Treatment and Survival, Report of the National Cancer Registry, National Cancer Registry: Cork, Ireland
32. NICE (National Institute for Health and Clinical Excellence) (2005) Irinotecan, Oxaliplatin and Raltitrexed for the Treatment of Advanced Colorectal Cancer. Technology appraisal no. 93 NICE: London
33. NCCN (2006a) Colon Cancer Clinical Practice Guidelines in Oncology (Version 1) National Comprehensive Cancer Network Inc. Available at http://www.nccn.org. Accessed 9 August 2007
34. NCCN (2006b) Rectal Cancer Clinical Practice Guidelines in Oncology (Version 1) 2006 National Comprehensive Cancer Network Inc. Available at http://www.nccn.org. Accessed 9 August 2007
35. O'Byrne K, Dalgleish A, Browning M, Steward W, Harris A (2000) The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 36: 151-169
36. Pitchforth E, Russell E, Van der Pol M (2002) Access to specialist cancer care: is it equitable? Br J Cancer 87: 1221-1226
37. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF (2002) Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20: 1192-1202
38. Rosen S, Buell J, Yoshida A, Kazsuba S, Hurst R, Michelassi F, Millis J, Posner M (2000) Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135: 530-534
39. Ruo L, Gougoutas C, Paty P, Guillem J, Cohen A, Wong W (2003) Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196: 722-728
40. Sarela A, Guthrie J, Seymour M, Ride E, Guillou P, O'Riordain D (2001) Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 88: 1352-1356
41. Sargent D, Goldberg R, Jacobson S, Macdonald J, Labianca R, Haller D, Shepherd L, Seitz J, Francini G (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345: 1091-1097
42. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, GRCS Group (2004) Preoperative vs postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740
43. Schrag D, Cramer LD, Bach PB, Begg CB (2001a) Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 93: 850-857
44. Schrag D, Gelfand S, Bach P, Guillem J, Minsky B, Begg C (2001b) Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results - Medicare. J Clin Oncol 19: 3712-3718
45. SIGN (Scottish Intercollegiate Guidelines Network) (2003) Management of Colorectal Cancer A National Clinical Guideline. No. 67 SIGN: Edinburgh
46. Temple L, Hsieh L, Wong W, Saltz L, Schrag D (2004) Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 22: 3475-3484
47. Twelves C, Wong A, Nowacki MP, Abt M, Burris III H, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kroning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Schuller J, Seitz JF, Stabuc B, Tujakowski J, Van Hazel G, Zaluski J, Scheithauer W. (2005) Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 352: 2696-2704
48. van der Bol J, Mathijssen R, Loos W, Friberg L, van Schaik R, de Jonge M, Planting A, Verweij J, Sparreboom A, de Jong F (2007) Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. J Clin Oncol 25: 2719-2726
49. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunler I, the EUROCARE-4 Working Group (2007) Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784 -796
50. Vulto J, Louwman W, Lybeert M, Poortmans P, Rutten H, Brenninkmeijer S, Coebergh J (2007) A population-based study of radiotherapy in a cohort of patients with rectal cancer diagnosed between 1996 and 2000. Eur J Surg Oncol 33: 993-997
51. Walsh P, Comber H (2007) Patterns of Care and Survival of Cancer Patients in Ireland 1994-2001: Time-trends and Regional Variation for Breast, Colorectal, Lung and Prostate Cancer. Summary report. National Cancer Registry: Cork
52. Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J (2003) Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Commun Health 57: 301-309
53. Yanbaeva D, Dentener M, Creutzberg E, Wesseling G, Wouters E (2007) Systemic effects of smoking. Chest 131: 1557-1566
54. Yancik R, Wesley M, Ries L, Havlik R, Long S, Edwards B, Yates J (1998) Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 82: 2123-2134